Connect with us

featured

More Than 200,000 People Were Arrested For Marijuana In The U.S. Last Year, FBI Data Shows

Published

on


Nearly 188,000 people were arrested over marijuana possession in the U.S. last year, according to the FBI’s latest annual crime report, and another 16,000 were booked for allegedly selling or growing cannabis. However, those figures are likely understated given inconsistencies in the federal data and questions about the agency’s methodology.

The full 2024 data set is based on more than 14 million criminal offenses reported to the Uniform Crime Reporting (UCR) Program, which is used to document and analyze national crime trends.  The report covers 95.6 percent of the U.S. population, FBI said.

This latest data does show that cannabis-related offenses fell slightly compared to 2023, dropping from 200,306 possession busts to 187,792 in 2024 and from 16,844 sales or manufacturing arrests to 16,244.

Advocates see the reduction as a reflection of the success of the expanding state-level legalization movement, but they also point out that marijuana is still the illegal substance that Americans are most arrested for possessing in the ongoing “war on drugs.”

“While the total number of marijuana-related arrests have fallen nationwide in recent years, it is clear that marijuana-related prosecutions still remain a primary driver of drug war enforcement in the United States,” NORML Deputy Director Paul Armentano told Marijuana Moment.

Of all drug possession arrests in the new report 27 percent were for marijuana—more than for any other specifically listed substance.

Because not all agencies provide complete data for the reporting periods, FBI has explained that the bureau calculates estimated crime numbers, essentially extrapolating “by following a standard estimation procedure using the data provided.” In terms of total reported arrests for a category labelled “drug/narcotic,” for example, FBI said there were 831,446 arrests.

At the same time, frustrations over FBI’s inconsistent data reporting on cannabis and other drug arrest trends have persisted. Various sections of the report provide different numbers for seemingly similar categories of offenses.

One FBI table says that there were 1,413,223 “Drug/Narcotic Offenses” in 2024. Another uses the figure for 1,577,175 under the same heading. A third puts the total at 1,870,804.

Another section says there were 822,488 arrests for drug abuse violations in 2024, accounting for about 12 percent of the approximately 7.5 million estimated arrests nationwide.

The FBI data also shows trends over time, indicating that there were 1,055,013 drug offenses charged in 2015 and 600,400 drug offenses charged in 2024—a reduction of about 43 percent, though it’s not clear how much of the change is due to the agency’s shifting methodology for reporting arrests and how much is due to actual changes in enforcement practices and state drug laws over the past decade.

In terms of controlled substances seized in 2024, the agency said were 386,540 marijuana seizures out of 1,072,704 total drug seizures, representing about 36 percent of enforcement actions.

FBI’s arrest data is widely relied on by lawmakers, researchers and media to understand and contextualize law enforcement trends. Any inconsistencies influence not just the public’s understanding of crime and law enforcement, but also potentially how policy is crafted and implemented.

Apparent errors in FBI marijuana were pointed out to the bureau in May 2022, when a longtime drug reformer and former congressional staffer, Eric Sterling, claimed to have discovered that a Maryland police department was reporting cannabis possession citations issued under the state’s decriminalization law at the time as arrests as part of a data-sharing partnership with FBI.

Since other state and local law enforcement agencies appear to not be reporting cannabis citations as arrests, Sterling reasoned, the inconsistent practice could significantly alter FBI’s annual reports—making it harder to draw reasonable policy conclusions from the data.

In 2023—about 14 months after Sterling sent the inquiry—the office finally replied. Rather than address the apparent problem, however, the Department of Justice’s (DOJ) Office of the Inspector General’s investigations division said it had “determined that the matters that you raised are more appropriate for review by another office within the DOJ” and referred the inquiry to FBI’s own inspection division.

FBI’s cannabis enforcement reporting is also compromised by the fact that local and state police are not required to share data to inform the agency’s annual report, meaning it offers an incomplete overview of national law enforcement activities. The agency itself says that certain data may not be comparable to previous years because of different levels of participation over time.


Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.


Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

Meanwhile, the Drug Enforcement Administration (DEA) said in a recent filing that the marijuana rescheduling process remains stalled at the stage it has been on for months, despite the head of agency’s prior commitment to senators that he would prioritize the issue if confirmed for the role.

President Donald Trump said in August that he intended to make a decision on the proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) within weeks.

Rescheduling would not federally legalize marijuana, however, so it remains to be seen how such a reform might impact arrest rates included in the FBI’s future annual reports.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

featured

Ohio House Passes Cannabis, Hemp Bill Resulting From ‘Venn Diagram From Hell’

Published

on


Ohio House lawmakers passed the 18th version of a bill on Oct. 22 that aims to alter the state’s adult-use cannabis laws that voters approved in 2023, while also creating a tightly defined regulatory framework for hemp products.

The 228-page legislation, Substitute Senate Bill 56, preserves many aspects of the voter-approved initiative, such as home grows (six per adult or 12 per household), sharing between adults 21 and older, and allocating 36% of cannabis excise tax revenues to local municipalities that host dispensaries.

However, the bill would prohibit public consumption at places like music concerts and bar patios, and those caught with cannabis purchased outside the state would be criminalized. No other state where cannabis is legal imposes such restrictions on out-of-state purchases, according to cannabis advocacy group NORML.

Advertisment: Frank Mayer » Frank Mayer Order 84 » CBT ROS Medium Rectangle 300x250 October 2025 » Frank Mayer CBT Web Ad - July 2025.jpg

In addition, while adults could continue to home cultivate cannabis under the legislation, they’d be restricted to harvesting more than 2.5 ounces of flower, or roughly one plant, with a felony penalty for those who grow more than the number of plants allowed. Also, the bill intends to place a 35% THC cap on flower and a 70% THC cap on extracts for both medical and adult-use cannabis.

Advertisment: Frank Mayer » Frank Mayer Order 84 » CBT ROS Medium Rectangle 300x250 October 2025 » Frank Mayer CBT Web Ad - July 2025.jpg

“This isn’t what Ohioans voted for, and the fact that this bill is being rushed through the Legislature, with almost no opportunity for public comment, indicates that lawmakers know they are undermining the will of the voters,” NORML Political Director Morgan Fox said in a public statement. “Regardless of where one stands on cannabis issues, everyone should be outraged at this.”

Advertisment: Emerald Harvest » Emerald Harvest Order 115 » CBT ROS Leaderboard Ad 728x90 October 2025 » eh-360-web-banner-728x90

The substitute bill found bipartisan House support in an 87-8 vote on Oct. 22.

Rep. Brian Stewart, R-Ashville, who carried Sub. S.B. 56 in the House, said Wednesday on the chamber floor that the bill “preserves all of the core aspects” of what voters passed two years ago, including access to tested and regulated products from licensed dispensaries.

Stewart also argued that the Legislature has to act to preserve the 36% tax revenue fund for host communities after the Ohio Department of Taxation flagged language in the voter-approved initiative, suggesting that the language failed to properly appropriate the money.

It was always going to require legislation in this chamber,” he said.

The substitute bill also intends to establish a legal pathway for licensed “hemp dispensaries” to sell regulated and tested intoxicating hemp products, defined as containing more than 0.5 milligrams of delta-9 THC per serving or 2 milligrams per package, or more than 0.5 milligrams of total non-delta-9 THC per package. These sales would be limited to those 21 and older. Those who sell intoxicating hemp products to those under 21 would be guilty of a misdemeanor on the first offense and a felony on a subsequent offense.

Meanwhile, cannabinoid hemp beverages would be defined and regulated differently with a $1.20-per-gallon excise tax (more on this later).

Stewart said provisions included in the 18th version of the substitute bill resulted from a “Venn diagram from hell” that attempted to balance individual liberties, consumer safety, the financial well-being of local communities, and the “need to protect the health and safety” of Ohio children.

“If you’re reading through it and you’re saying, ‘Rep. Stewart, I don’t like Section X, I don’t like Section Y,’ please know you’re in good company. I don’t either,” he said. “This is not the bill that I originally introduced. It’s not the bill that Representative [Tex] Fischer originally introduced. But it is a carefully crafted compromise that makes Ohio better.”

While the Senate passed its version of the legislation in February, cannabis advocacy groups like the Marijuana Policy Project applauded the House Judiciary Committee for sitting on the legislation for nearly eight months as a means to prevent recriminalization measures “pushed by the Senate.”

However, many House members said during this week’s floor debate that Gov. Mike DeWine’s executive order issued Oct. 8 – one that attempts to shut down hemp-derived cannabinoid product sales and initiate emergency rulemaking – spurred lawmakers to go back to the drawing board for a legislative fix.

DeWine showcased various intoxicating hemp products in packaging that mimicked popular candies, like Nerds, Sour Patch Kids and Gushers, during his Oct. 8 press conference.

After lawmakers were at an impasse, DeWine’s executive order represented a turning point on Sub. S.B. 56, Rep. Tex Fischer, R-Boardman, said before Wednesday’s floor vote.

I think we all had an agreement that that was not the intent of the hemp legislation at the federal level or here in Ohio, but we did need to do something to protect kids from these products,” he said. “Some of these products are truly illicit and truly dangerous, and everybody, no matter how fervent of an activist on the hemp side of this issue you were, agreed something needed to be done.”

Legislative disagreements had revolved around Ohio businesses that would be negatively impacted by language in previous versions of the bill, Fischer said.

Under the House-passed substitute bill, places where children “walk freely,” like gas stations and grocery stores, would be prohibited from selling intoxicating hemp products, while certain intoxicating hemp retailers, such as a qualifying vape shop, would be “grandfathered in” for licensure.

For a retailer to qualify for a grandfathered-in hemp dispensary license, that retailer must have sold intoxicating hemp products on or before Aug. 30, and the store’s receipts from hemp and intoxicating hemp product sales must have exceeded 80% of its total gross receipts for either the past 12 months or the 2024 calendar year.

What about those people that have poured their blood, sweat, tears, years of work, potentially millions of dollars into building a business living by the rules that we set out, whether they were adequate or not, they were not breaking the law,” Fischer said. “Those were the people that I was motivated to stand up for, and while this bill doesn’t do everything that I wanted or everything that others want, I believe we have arrived at a reasonable conclusion to allow those people to still stay in business, to grandfather them into this new regulatory regime.”

No one under the age of 21 would be allowed inside these hemp dispensaries, which would be prohibited from selling cigarettes, tobacco, and vape or electronic smoking products under the bill. No more than 400 hemp dispensaries would be allowed in the state, unless those grandfathered in exceed that number.

While the biennial license renewal fee for Ohio’s cannabis dispensaries is $70,000, the two-year renewal license fee for a grandfathered-in hemp dispensary would be $35,000 under Sub. S.B. 56.

Meanwhile, hemp beverages, which the substitute bill defines as “drinkable cannabinoid products,” would be regulated differently. In addition, these products would be classified as low-level DCPs (5 milligrams or less of total THC per serving) or high-level DCPs (5-10 milligrams of total THC per serving). Only one serving per container would be allowed.

Neither low-level nor high-level DCPs would constitute an “intoxicating hemp product,” with DCPs falling under a separate regulatory framework for manufacturers, distributors and retailers. Still, sales to those under 21 would be prohibited.

Ohio retailers with Class C liquor licenses, such as grocery stores that sell alcohol for carryout only, would be allowed to sell high-level DCPs. Meanwhile, Ohio retailers with licenses for on-site consumption, such as restaurants and bars, would be allowed to sell low-level DCPs.

While the substitute bill would allow DCP manufacturers to create higher-dose beverages that contain more than 10 milligrams of THC, they would be restricted to distributing and/or selling those products to out-of-state partners.

Fischer said there were a lot of wins “for us so-called ‘hemp-resentatives,’” in the substitute bill.  

Many of you heard from beverage manufacturers, bars, restaurants, retailers about how popular these products are, but there are also a lot of folks that weren’t yet comfortable stocking these products because of the regulatory uncertainty that is a result of our inability to previously come to an agreement here in Columbus,” he said. “I think this strikes the appropriate tone of a reasonable, fair and pro-business regulatory regime while still maintaining that these products and consumers should be safe.”

While it’s unclear if the Senate will agree to the House’s amended substitute bill or take the legislation to a conference committee for further debate – before possibly sending the bill to DeWine’s desk – the potential outcomes are significant for Ohio stakeholders: cannabis businesses, hemp businesses, consumers, patients and children.

Rep. Jamie Callender, R-Concord, a long-time advocate for cannabis reform in the Buckeye State, acknowledged the legislation “is not perfect” before voting to support the bill.

Callender said a “no” vote on the legislation represents allowing retailers to continue selling high-THC products to children walking home from schools with impunity.

“I imagine everybody in this room can find at least one thing they don’t like in the bill, one thing they think can be improved on,” he said. “You have my commitment. I’ll keep working with everyone to make it better, but I believe we have to act.”



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

What To Know About Cannabis And A Brain Aneurysm

Published

on


Discover what to know about cannabis and a brain aneurysm—risks, recovery, and medical cautions.

When celebrity Kim Kardashian recently revealed she was diagnosed with a small brain aneurysm—reportedly detected during a routine MRI and attributed by her doctors to stress—her disclosure sparked interest in a condition most people don’t know much about. A brain aneurysm is a bulging or ballooning blood vessel in the brain, which can be life-threatening if it ruptures. With growing interest around cannabis use—both medically and recreationally—it’s worth exploring what to know about cannabis and a brain aneurysm.

RELATED: The Science Behind Cannabis And Happiness

A brain aneurysm (sometimes called an intracranial aneurysm) occurs when a weakened area of a blood vessel in the brain bulges outward. If the aneurysm ruptures, it can lead to a major bleed called a subarachnoid hemorrhage—a medical emergency. Many aneurysms remain small and never rupture, but risk factors include high blood pressure, smoking, genetic predisposition, and possibly vascular stress. Kim Kardashian’s case underlines how even individuals with public profiles and access to healthcare can face this silent risk.

What To Know About Cannabis And A Brain Aneurysm

Cannabis—or more precisely its components such as cannabidiol (CBD) and tetrahydrocannabinol (THC)—has been studied for a variety of health issues. For some conditions like chronic pain, certain forms of epilepsy, or spasticity in multiple sclerosis, cannabinoids may offer symptomatic relief. There is emerging evidence medical marijuana can improve quality of life for some patients: reducing pain, improving sleep or mood, and even decreasing reliance on opioids in certain contexts.

In the broad sense, in jurisdictions across the U.S., many patients use it under medical supervision for conditions like migraine, nausea from chemotherapy, or chronic neuropathic pain. “Medical” use does not equate to “safe in all contexts”—especially when other serious medical issues are present.

When it comes to brain aneurysms—particularly after diagnosis or treatment—the research raises caution flags about cannabis use:

  • Studies show people who have had an aneurysmal subarachnoid hemorrhage (a burst aneurysm), cannabis users had higher rates of delayed cerebral ischemia (DCI)—a serious complication which can lead to poor outcome. One large study found cannabis users had about a 2.7 times greater risk of DCI compared with non-users.
  • Other studies link recreational cannabis use to a higher likelihood of having an aneurysm rupture in the first place—one estimate suggested about an 18 % increased risk.
  • Research also suggests cannabis affects vascular tone, cerebral blood flow, mitochondrial function in brain cells, and may contribute to vasospasm (narrowing of blood vessels) or oxidative stress—mechanisms which are particularly concerning in someone with a vulnerable blood vessel wall.
  • One review warned even for unruptured aneurysms, if cannabis is used, individuals should be aware they may face worse outcomes should rupture occur.

RELATED: Evidence About Burning Mouth Syndrome And Cannabinoids

If you or someone you know has been diagnosed with a brain aneurysm (ruptured or unruptured), here are some practical steps:

  • Talk to your neurologist/neurosurgeon about cannabis use. The research suggests elevated risks in people with aneurysms who use cannabis.
  • Avoid assuming “medical use = safe.” Even if you’re using cannabis under a physician’s care, an aneurysm changes the risk profile.
  • Focus on established risk-reduction: control blood pressure, stop smoking, manage cholesterol, avoid stimulants. These traditional strategies remain foundational.
  • If you have an untreated aneurysm and are considering cannabis for medical reasons, proceed with caution.Ask your medical team about the specific size, location, treatment plan of your aneurysm and whether there are recommended restrictions.
  • After an aneurysm rupture or treatment, strongly consider abstaining or closely monitoring any cannabis use. The data indicate increased complication rates in this particular setting.

The public disclosure by Kim Kardashian highlights how common aneurysms may be, but it also reminds us the decision to use cannabis in a medical context should be made carefully. While cannabis offers genuine medical benefits for some conditions, when a brain aneurysm is in the picture—especially one which has ruptured or is being observed—caution is warranted. Speak with a neurologist familiar with cerebrovascular risk, weigh the benefits and the unique risks, and make an informed choice rather than assuming “legal = safe.”



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

MariMed to Expand Brand Distribution to New York

Published

on


[PRESS RELEASE] – NORWOOD, Mass., Oct. 23, 2025 – MariMed Inc., a leading cannabis consumer packaged goods company and retailer, announced a licensing agreement with Farm 2 Hand LLC, a New York State cannabis license holder, that will introduce the company’s top-selling portfolio of products throughout New York State. Terms of the agreement were not disclosed.

Farm 2 Hand intends to manufacture and distribute a variety of MariMed’s edible products as permitted under New York regulations. Those are initially expected to include Betty’s Eddies fruit chews; Bubby’s Baked baked goods; and InHouse gummies. The products will be produced in a new kitchen that MariMed will design and equip for Farm 2 Hand at Farm 2 Hand’s Bronx production facility.

Advertisment: Frank Mayer » Frank Mayer Order 84 » CBT ROS Medium Rectangle 300x250 October 2025 » Frank Mayer CBT Web Ad - July 2025.jpg

“Expanding the availability of our brands to the Empire State and its $6 billion total addressable market marks a significant step forward in our plan to own top-selling cannabis brands across the U.S.,” MariMed CEO Jon Levine said. “The addition of New York to our distribution footprint will help drive wholesale revenue, and being in the nation’s top media and influencer market will also help increase national awareness for our brands.”

Advertisment: Frank Mayer » Frank Mayer Order 84 » CBT ROS Medium Rectangle 300x250 October 2025 » Frank Mayer CBT Web Ad - July 2025.jpg

The company expects its products will be available to New York’s 500-plus dispensaries in 2026, following the build-out of the kitchen and regulatory approval.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
featured7 hours ago

Ohio House Passes Cannabis, Hemp Bill Resulting From ‘Venn Diagram From Hell’

featured8 hours ago

What To Know About Cannabis And A Brain Aneurysm

featured9 hours ago

MariMed to Expand Brand Distribution to New York

featured10 hours ago

Time for a Cannabis Reboot: Local Roots, Fair Markets, Real Change

featured11 hours ago

Ohio Health Agency Grants $400,000 To Fund Psychedelics Education And Training For First Responders, Doctors And More

featured13 hours ago

Curio Wellness Acquires 4 Greenlight Dispensaries in Missouri

202514 hours ago

The best places to be high in Seattle

featured14 hours ago

Colombia’s Bold Offer to Trump: Legal Weed Exports for Peace

featured15 hours ago

Trump DOJ Asks Supreme Court For Delayed Schedule In Case On Marijuana Users’ Gun Rights

featured16 hours ago

Whiskey Company Scales Back Operations, Citing ‘Consumer Shifts’ Toward Marijuana As Alcohol Alternative

featured17 hours ago

Smart Cannabis: The AI Revolution No Operator Can Ignore

featured18 hours ago

New Jersey Gubernatorial Candidates Need To Step Up For Cannabis Consumers (Op-Ed)

featured19 hours ago

Millennials Are Spending Big on Luxury Travel

featured20 hours ago

West Virginia Medical Marijuana Revenue Is Supposed To Support Drug Treatment Programs, But Sits Unspent As Officials Worry About Federal Prohibition

featured21 hours ago

Frequent Marijuana Use Is Tied To Lower Risk Of Liver Disease From Alcohol, New Study Finds

featured22 hours ago

Ohio bill to scale back cannabis legalization passed by House (Newsletter: October 23, 2025)

featured1 day ago

FDA Weighs Petition On ‘Significant Harm’ Of Marijuana Hair Testing Device’s Positive Results From Secondhand Smoke

featured1 day ago

Wisconsin Lawmakers Rally for Medical Cannabis Legalization in Committee Hearing

featured1 day ago

Massachusetts Campaign To Roll Back Marijuana Legalization Law Is ‘On Track’ To Make 2026 Ballot, Spokesperson Says

featured1 day ago

Village Farms Introduces Industry-First, One-Way Aroma Valve in Cannabis Packaging

featured1 day ago

Ohio House Passes Bill To Remove Voter-Approved Marijuana Legalization Protections And Restrict Hemp Market

featured2 days ago

Sorting Robotics Becomes Cannabis Manufacturing’s First True Systems Integrator

featured2 days ago

Wisconsin Senators Hold Hearing On GOP Leader’s New Medical Marijuana Legalization Bill

featured2 days ago

Tariffs And Visas Add To The Cannabis Industry’s Misery

California Cannabis Updates1 year ago

Alert: Department of Cannabis Control updates data dashboards with full data for 2023 

Breaking News1 year ago

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

best list1 year ago

5 best CBD creams of 2024 by Leafly

Business1 year ago

Recreational cannabis on ballot for third time in South Dakota

Business1 year ago

EU initiative begins bid to open access to psychedelic therapies

cbd1 year ago

New Study Analyzes the Effects of THCV, CBD on Weight Loss

Bay Smokes1 year ago

Free delta-9 gummies from Bay Smokes

autoflower seeds1 year ago

5 best autoflower seed banks of 2024 by Leafly

cannabis brands1 year ago

Discover New York’s dankest cannabis brands [September 2024]

California1 year ago

May 2024 Leafly HighLight: Pink Runtz strain

Hemp1 year ago

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

best list1 year ago

5 best THC drinks of 2024 by Leafly

Mississippi Cannabis News1 year ago

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

best list1 year ago

6 best CBD gummies of 2024 by Leafly

Breaking News1 year ago

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

Mississippi Cannabis News1 year ago

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

best list1 year ago

5 best delta-9 THC gummies of 2024 by Leafly

Arkansas1 year ago

The Daily Hit: October 2, 2024

Mississippi Cannabis News1 year ago

Mississippi city official pleads guilty to selling fake CBD products

Breaking News1 year ago

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

Breaking News1 year ago

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

best list1 year ago

5 best THCA flower of 2024 by Leafly

best list12 months ago

6 best hemp pre-rolls of 2024 by Leafly

Breaking News1 year ago

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

Trending